EG18643A - Pharmaceutical compositions containing trapidil,a process for the preparation thereof and related therapeutic use - Google Patents

Pharmaceutical compositions containing trapidil,a process for the preparation thereof and related therapeutic use

Info

Publication number
EG18643A
EG18643A EG414/88A EG41488A EG18643A EG 18643 A EG18643 A EG 18643A EG 414/88 A EG414/88 A EG 414/88A EG 41488 A EG41488 A EG 41488A EG 18643 A EG18643 A EG 18643A
Authority
EG
Egypt
Prior art keywords
pharmaceutical compositions
preparation
compositions containing
therapeutic use
related therapeutic
Prior art date
Application number
EG414/88A
Other languages
English (en)
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of EG18643A publication Critical patent/EG18643A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
EG414/88A 1987-07-31 1988-07-31 Pharmaceutical compositions containing trapidil,a process for the preparation thereof and related therapeutic use EG18643A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21540/87A IT1222414B (it) 1987-07-31 1987-07-31 Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico

Publications (1)

Publication Number Publication Date
EG18643A true EG18643A (en) 1993-08-30

Family

ID=11183318

Family Applications (1)

Application Number Title Priority Date Filing Date
EG414/88A EG18643A (en) 1987-07-31 1988-07-31 Pharmaceutical compositions containing trapidil,a process for the preparation thereof and related therapeutic use

Country Status (14)

Country Link
EP (1) EP0301423B1 (xx)
JP (1) JPS6463521A (xx)
KR (1) KR890001559A (xx)
AT (1) ATE104848T1 (xx)
AU (1) AU614297B2 (xx)
DE (1) DE3889259T2 (xx)
DK (1) DK427388A (xx)
EG (1) EG18643A (xx)
ES (1) ES2063007T3 (xx)
IE (1) IE64158B1 (xx)
IT (1) IT1222414B (xx)
NZ (1) NZ225628A (xx)
PT (1) PT88142B (xx)
ZA (1) ZA885586B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
IT1301947B1 (it) * 1998-07-28 2000-07-20 Chiesi Farma Spa Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
JP6078514B2 (ja) * 2014-10-30 2017-02-08 コリア ユナイテッド ファーム,インク 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠
EP3442538A4 (en) 2016-04-04 2019-11-20 Sinopia Biosciences, Inc. TREATMENT OF EXTRAPYRAMIDAL SYNDROME WITH TRAPIDILE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
EP0187433B1 (en) * 1983-08-01 1990-12-27 Teijin Limited Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
EP0207638B1 (en) * 1985-06-04 1990-12-19 Teijin Limited Sustained-release pharmaceutical preparation
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
DE3873812D1 (de) * 1987-04-07 1992-09-24 Ciba Geigy Ag 3h-1,2,3-triazolo(4,5-d)pyrimidine.

Also Published As

Publication number Publication date
DE3889259T2 (de) 1994-08-11
DE3889259D1 (de) 1994-06-01
IT1222414B (it) 1990-09-05
EP0301423B1 (en) 1994-04-27
PT88142B (pt) 1995-03-01
JPS6463521A (en) 1989-03-09
DK427388A (da) 1989-02-01
IT8721540A0 (it) 1987-07-31
NZ225628A (en) 1991-04-26
IE64158B1 (en) 1995-07-12
PT88142A (pt) 1989-06-30
ES2063007T3 (es) 1995-01-01
AU614297B2 (en) 1991-08-29
DK427388D0 (da) 1988-07-29
AU2022688A (en) 1989-04-20
ZA885586B (en) 1989-04-26
IE882332L (en) 1989-01-31
EP0301423A1 (en) 1989-02-01
ATE104848T1 (de) 1994-05-15
KR890001559A (ko) 1989-03-27

Similar Documents

Publication Publication Date Title
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
CS782686A2 (en) Method of benzimidazole derivatives production
FI885884A0 (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
ZM489A1 (en) Chemical compounds
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
HUT42080A (en) Process for producing labdane derivatives and pharmaceutical compositions containing them
HUT47865A (en) Process for producing pharmaceutical compositions containing somatostatin as active component
CS405391A3 (en) N-aminobutyl-n-phenylarylamide derivatives, process of their preparationand pharmaceutical compositions containing said derivatives
HUT46224A (en) Process for producing pharmaceutical compositions containing prostaglandin e1-derivatives
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
AU4861693A (en) New chromene compounds having a triene side chain, process for the preparation thereof, and pharmaceutical compositions containing them
IL87856A0 (en) Alkadiene derivatives,process for their preparation and pharmaceutical compositions containing them
EG18643A (en) Pharmaceutical compositions containing trapidil,a process for the preparation thereof and related therapeutic use
HUT45256A (en) Process for producing 1,3,4,9-tetrahydropyrano/3,4-b/indol-1-acetic acid derivatives and pharmaceutical composition containing them
ATE55250T1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
IL82145A0 (en) Substituted thiacycloalkeno(3,2-b)pyridines,their preparation and pharmaceutical compositions containing them
ATE44950T1 (de) Polyprenylverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
HUT47020A (en) Process for production of stabilly injectable medical compounds containing as active substance 1,4-dihidroxi-5,8-bis/2/2-hidroxi-ethil-amin/-ethil-amin-antraquinon-dihydrochlorid
EG18272A (en) Process for preparing ergolene derivatives,pharmaceutical compositions containing them
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE3661073D1 (en) Thiophene acetic-acid derivatives, process for their preparation, intermediates obtained, their use as therapeutic agents and pharmaceutical compositions containing them
HUT46693A (en) Process for producing dioxabicyclo/3,3,0/oktanon-oxim-ethers and pharmaceutical compositions containing them as active components
IL89015A0 (en) Tetrahydropyridine derivatives,their preparation and pharmaceutical compositions containing them
HU886315D0 (en) Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents
EP0280627A3 (en) Derivatives of n-substituted alpha-mercaptomethyl-benzene-propanamide, process for their preparation, their use as medicines and compositions containing them